Hyperhomocysteinemia, Insulin Resistance and High HS-CRP Levels in Prehypertension

被引:11
作者
Talikoti, Prashanth [1 ]
Bobby, Zachariah [2 ]
Hamide, Abdoul [3 ]
机构
[1] Meenakshi Med Coll Hosp & Res Inst, Dept Biochem, Kanchipurum, India
[2] Jipmer, Dept Biochem, Pondicherry, India
[3] Jipmer, Dept Internal Med, Pondicherry, India
关键词
hs-CRP; Hyperhomocysteinemia; Insulin resistance; Prehypertension;
D O I
10.7860/JCDR/2014/8945.4669
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pre-hypertension refers to blood pressure in the range of 120 to 139 mm of Hg/80 to 89 mm of Hg and its prevalence is increasing in India. Previous studies have documented the increase in homocysteine, C-reactive protein and insulin resistance and their role in the development of hypertension. In recent years much attention has been focused on subjects with prehypertension, as the risk for development of cardiovascular disease is higher in these subjects compared to those with normal blood pressure. Objectives: To evaluate the serum homocysteine, hs-CRP level and insulin resistance in subjects with prehypertension. Materials and Methods: Sixty prehypertensives and 32 normotensives were recruited according to Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of blood pressure (JNC 7) guidelines. Serum homocysteine, vitamin B12, folate, insulin, hs-CRP and lipid profile were analysed. Independent t-test was carried out to compare two groups and pearson correlation analyses were carried out between various parameters with systolic blood pressure (SBP) and diastolic blood pressure (DBP). Results: Cardiovascular risk factors like serum homocysteine, insulin resistance and inflammatory marker hs-CRP were significantly increased in prehypertensives. Total cholesterol, TG, LDL-C and VLDL-C were significantly increased when compared to normotensives. Serum homocysteine correlated positively and vitamin B12 and folate negatively with Systolic Blood Pressure. Conclusion: The present study concludes that the established cardiovascular risk factors, homocysteine, insulin resistance, and hs-CRP which have roles in the etiopathogenesis of hypertension, were elevated in subjects with prehypertension. Thus, early detection and life style modification may reduce the risk or delay the onset of hypertension and other cardiovascular complications.
引用
收藏
页码:CC7 / CC9
页数:3
相关论文
共 20 条
[1]  
Chamber JC, 2007, CIRCULATION, V102, P2479
[2]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[3]   Association between prehypertension status and inflammatory markers related to atherosclerotic disease - The ATTICA study [J].
Chrysohoou, C ;
Pitsavos, C ;
Panagiotakos, DB ;
Skoumas, J ;
Stefanadis, C .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (07) :568-573
[4]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[5]  
Das UN, 2003, NUTRITION, V19, P686
[6]   Plasma homocysteine concentration and blood pressure in young adult African Americans [J].
Dinavahi, R ;
Cossrow, N ;
Kushner, H ;
Falkner, B .
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (09) :767-770
[7]   Prehypertension is associated with insulin resistance [J].
Hwu, C. -M. ;
Liou, T. -L. ;
Hsiao, L. -C. ;
Lin, M. -W. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2009, 102 (10) :705-711
[8]   Associations of Plasma Homocysteine Levels with Arterial Stiffness in Prehypertensive Individuals [J].
Kim, Byung Jin ;
Seo, MiHae ;
Huh, Jung Kwon ;
Kwon, Chang Hee ;
Kim, Jung Tae ;
Sung, Ki Chul ;
Kim, Bum Soo ;
Kang, Jin Ho .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2011, 33 (06) :411-417
[9]  
King Dana E, 2004, J Clin Hypertens (Greenwich), V6, P562, DOI 10.1111/j.1524-6175.2004.03577.x
[10]  
Martin Jose F V, 2009, Recent Pat Cardiovasc Drug Discov, V4, P133